The Role of Circulating Tumor (ct)DNA Testing/Monitoring in Stage II-III Colorectal Cancer

February 15, 2021
Christopher Lieu, MD, Anschutz Medical Campus

Sepideh Gholami, MD, FACS, UC Davis Comprehensive Cancer Center

Two experts in the management of colorectal cancer discuss the evolving role of circulating tumor (ct)DNA testing/monitoring in stage II and III disease.